Use and Outcomes of Triple Therapy Among Older Patients With Acute Myocardial Infarction and Atrial Fibrillation

January, 2014, 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society, J Am Coll Cardiol, 64, e1, 10.1016/j.jacc.2014.03.022 Jneid, 2012, J Am Coll Cardiol, 60, 645, 10.1016/j.jacc.2012.06.004 Sørensen, 2009, Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data, Lancet, 374, 1967, 10.1016/S0140-6736(09)61751-7 Lamberts, 2012, Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: a nationwide cohort study, Circulation, 126, 1185, 10.1161/CIRCULATIONAHA.112.114967 Fosbol, 2012, Safety and effectiveness of antithrombotic strategies in older adult patients with atrial fibrillation and non-ST elevation myocardial infarction, Am Heart J, 163, 720, 10.1016/j.ahj.2012.01.017 DeWilde, 2014, Triple therapy for atrial fibrillation and percutaneous coronary intervention: a contemporary review, J Am Coll Cardiol, 64, 1270, 10.1016/j.jacc.2014.06.1193 Ruiz-Nodar, 2008, Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis, J Am Coll Cardiol, 51, 818, 10.1016/j.jacc.2007.11.035 Lopes, 2010, Warfarin use and outcomes in patients with atrial fibrillation complicating acute coronary syndromes, Am J Med, 123, 134, 10.1016/j.amjmed.2009.09.015 Wang, 2008, Discharge antithrombotic strategies among patients with acute coronary syndrome previously on warfarin anticoagulation: physician practice in the CRUSADE registry, Am Heart J, 155, 361, 10.1016/j.ahj.2007.09.003 Lopes, 2012, Atrial fibrillation and acute myocardial infarction: antithrombotic therapy and outcomes, Am J Med, 125, 897, 10.1016/j.amjmed.2012.04.006 Hess, 2012, Antithrombotic therapy for atrial fibrillation and coronary artery disease in older patients, Am Heart J, 164, 607, 10.1016/j.ahj.2012.07.004 Lip, 2010, Eur Heart J, 31, 1311, 10.1093/eurheartj/ehq117 Peterson, 2009, A call to ACTION (Acute Coronary Treatment and Intervention Outcomes Network): a national effort to promote timely clinical feedback and support continuous quality improvement for acute myocardial infarction, Circ Cardiovasc Qual Outcomes, 2, 491, 10.1161/CIRCOUTCOMES.108.847145 Hammill, 2009, Linking inpatient clinical registry data to Medicare claims data using indirect identifiers, Am Heart J, 157, 995, 10.1016/j.ahj.2009.04.002 Gage, 2001, Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation, JAMA, 285, 2864, 10.1001/jama.285.22.2864 Fang, 2011, A new risk scheme to predict warfarin-associated hemorrhage: the ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study, J Am Coll Cardiol, 58, 395, 10.1016/j.jacc.2011.03.031 Zalesak, 2013, Higher persistence in newly diagnosed nonvalvular atrial fibrillation patients treated with dabigatran versus warfarin, Circ Cardiovasc Qual Outcomes, 6, 567, 10.1161/CIRCOUTCOMES.113.000192 Mega, 2012, Antithrombotic therapy: triple therapy or triple threat?, Hematology Am Soc Hematol Educ Program, 2012, 547, 10.1182/asheducation.V2012.1.547.3798919 Holmes, 2009, Combining antiplatelet and anticoagulant therapies, J Am Coll Cardiol, 54, 95, 10.1016/j.jacc.2009.03.044 Lamberts, 2013, Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention, J Am Coll Cardiol, 62, 981, 10.1016/j.jacc.2013.05.029 Nguyen, 2007, Combining warfarin and antiplatelet therapy after coronary stenting in the Global Registry of Acute Coronary Events: is it safe and effective to use just one antiplatelet agent?, Eur Heart J, 28, 1717, 10.1093/eurheartj/ehm186 Fosbol, 2013, Warfarin use among older atrial fibrillation patients with non-ST-segment elevation myocardial infarction managed with coronary stenting and dual antiplatelet therapy, Am Heart J, 166, 864, 10.1016/j.ahj.2013.08.005 Faxon, 2011, Consensus document: antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting. A North-American perspective, Thromb Haemost, 106, 572 Dewilde, 2013, Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial, Lancet, 381, 1107, 10.1016/S0140-6736(12)62177-1 Dans, 2013, Concomitant use of antiplatelet therapy with dabigatran or warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial, Circulation, 127, 634, 10.1161/CIRCULATIONAHA.112.115386 Alexander, 2011, Apixaban with antiplatelet therapy after acute coronary syndrome, N Engl J Med, 365, 699, 10.1056/NEJMoa1105819 Khazanie, 2014, Outcomes of medicare beneficiaries with heart failure and atrial fibrillation, J Am Coll Cardiol HF, 2, 41 Pisters, 2010, A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey, Chest, 138, 1093, 10.1378/chest.10-0134 Gage, 2006, Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF), Am Heart J, 151, 713, 10.1016/j.ahj.2005.04.017